Cargando…

DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection

INTRODUCTION: The clinical practicability of DNA microarray chip in detecting the presence of mycobacterial species/isolates directly in the skin tissues has not been evaluated, nor the efficacy of DNA microarray chip as a novel diagnostic tool for the early diagnosis of cutaneous mycobacterial infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qian, Wang, Yuanyuan, Gao, Zhiqin, Yang, Hong, Liu, Siyu, Tan, Jingwen, Yang, Lianjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349391/
https://www.ncbi.nlm.nih.gov/pubmed/37457951
http://dx.doi.org/10.3389/fcimb.2023.1183078
_version_ 1785073890805940224
author Yu, Qian
Wang, Yuanyuan
Gao, Zhiqin
Yang, Hong
Liu, Siyu
Tan, Jingwen
Yang, Lianjuan
author_facet Yu, Qian
Wang, Yuanyuan
Gao, Zhiqin
Yang, Hong
Liu, Siyu
Tan, Jingwen
Yang, Lianjuan
author_sort Yu, Qian
collection PubMed
description INTRODUCTION: The clinical practicability of DNA microarray chip in detecting the presence of mycobacterial species/isolates directly in the skin tissues has not been evaluated, nor the efficacy of DNA microarray chip as a novel diagnostic tool for the early diagnosis of cutaneous mycobacterial infections is known. METHODS: The present study analyzed the incidence of cutaneous mycobacterial infections in Shanghai and explored the efficacy of a novel DNA microarray chip assay for the clinical diagnosis of the disease from skin tissue specimens compared to traditional detection methods. A total of 60 participants fulfilling the defined diagnostic criteria and confirmed positive for cutaneous mycobacterial infections from 2019 to 2021 were enrolled in the study. Subsequent to recording the participants’ medical history and clinical characteristics, the skin tissue specimens were collected for analyses. The specimens underwent histopathological analyses, skin tissue culture, and DNA microarray chip assay. RESULTS: Increased incidence of cutaneous mycobacterial infection was detected from 2019 to 2021. The most common infecting pathogen was M. marinum followed by M. abscessus. The sensitivity, specificity and accuracy of the skin tissue culture method were 70%, 100% and 76.62%, respectively, while that of the DNA microarray chip assay were 91.67%, 100% and 93.51%, respectively. The sensitivity and accuracy of the DNA microarray chip assay were significantly higher than those of the skin tissue culture method. The positive likelihood and diagnostic odds ratio were >10 and >1, respectively for both the methods. The negative likelihood ratio was significantly higher (30% vs 8.33%) and the Youden’s index was significantly lower (70.00% vs 91.67%) in the skin culture method compared to that of the DNA microarray chip assay. There was a significant association of false negative results with a history of antibiotic use in the skin tissue culture method. DISCUSSION: Given the increasing incidence of cutaneous mycobacterial infections, early diagnosis remains a prime clinical focus. The DNA microarray chip assay provides a simple, rapid, high-throughput, and reliable method for the diagnosis of cutaneous mycobacterial infections with potential for clinical application.
format Online
Article
Text
id pubmed-10349391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103493912023-07-16 DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection Yu, Qian Wang, Yuanyuan Gao, Zhiqin Yang, Hong Liu, Siyu Tan, Jingwen Yang, Lianjuan Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: The clinical practicability of DNA microarray chip in detecting the presence of mycobacterial species/isolates directly in the skin tissues has not been evaluated, nor the efficacy of DNA microarray chip as a novel diagnostic tool for the early diagnosis of cutaneous mycobacterial infections is known. METHODS: The present study analyzed the incidence of cutaneous mycobacterial infections in Shanghai and explored the efficacy of a novel DNA microarray chip assay for the clinical diagnosis of the disease from skin tissue specimens compared to traditional detection methods. A total of 60 participants fulfilling the defined diagnostic criteria and confirmed positive for cutaneous mycobacterial infections from 2019 to 2021 were enrolled in the study. Subsequent to recording the participants’ medical history and clinical characteristics, the skin tissue specimens were collected for analyses. The specimens underwent histopathological analyses, skin tissue culture, and DNA microarray chip assay. RESULTS: Increased incidence of cutaneous mycobacterial infection was detected from 2019 to 2021. The most common infecting pathogen was M. marinum followed by M. abscessus. The sensitivity, specificity and accuracy of the skin tissue culture method were 70%, 100% and 76.62%, respectively, while that of the DNA microarray chip assay were 91.67%, 100% and 93.51%, respectively. The sensitivity and accuracy of the DNA microarray chip assay were significantly higher than those of the skin tissue culture method. The positive likelihood and diagnostic odds ratio were >10 and >1, respectively for both the methods. The negative likelihood ratio was significantly higher (30% vs 8.33%) and the Youden’s index was significantly lower (70.00% vs 91.67%) in the skin culture method compared to that of the DNA microarray chip assay. There was a significant association of false negative results with a history of antibiotic use in the skin tissue culture method. DISCUSSION: Given the increasing incidence of cutaneous mycobacterial infections, early diagnosis remains a prime clinical focus. The DNA microarray chip assay provides a simple, rapid, high-throughput, and reliable method for the diagnosis of cutaneous mycobacterial infections with potential for clinical application. Frontiers Media S.A. 2023-07-01 /pmc/articles/PMC10349391/ /pubmed/37457951 http://dx.doi.org/10.3389/fcimb.2023.1183078 Text en Copyright © 2023 Yu, Wang, Gao, Yang, Liu, Tan and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Yu, Qian
Wang, Yuanyuan
Gao, Zhiqin
Yang, Hong
Liu, Siyu
Tan, Jingwen
Yang, Lianjuan
DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title_full DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title_fullStr DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title_full_unstemmed DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title_short DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
title_sort dna microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349391/
https://www.ncbi.nlm.nih.gov/pubmed/37457951
http://dx.doi.org/10.3389/fcimb.2023.1183078
work_keys_str_mv AT yuqian dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT wangyuanyuan dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT gaozhiqin dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT yanghong dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT liusiyu dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT tanjingwen dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection
AT yanglianjuan dnamicroarraychipassayinnewuseearlydiagnosticvalueincutaneousmycobacterialinfection